What is American Oncology Network Earnings Yield (Joel Greenblatt) %?
American Oncology Network's Enterprise Value for the quarter that ended in Mar. 2024 was $0.00 Mil.
American Oncology Network's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-68.04 Mil. American Oncology Network's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2024 was -22.37%.
The historical rank and industry rank for American Oncology Network's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
During the past 4 years, the highest Earnings Yield (Joel Greenblatt) of American Oncology Network was 10.50%. The lowest was -68.03%. And the median was -13.36%.
AONCW's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.6 * Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. American Oncology Network's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
American Oncology Network Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for American Oncology Network's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
American Oncology Network Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of American Oncology Network's Earnings Yield (Joel Greenblatt) %
For the Medical Care Facilities subindustry, American Oncology Network's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Oncology Network's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, American Oncology Network's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where American Oncology Network's Earnings Yield (Joel Greenblatt) % falls into.
American Oncology Network Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
American Oncology Networks Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as
American Oncology Network's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-68.04 Mil.
American Oncology Network (OTCPK:AONCW) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
American Oncology Network Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of American Oncology Network's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
American Oncology Network (American Oncology Network) Business Description
American Oncology Network Inc Formerly American Oncology Network LLC is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services through 24 oncology practices located in Arkansas, Louisiana, Indiana, Virginia, Ohio, Nevada, Iowa, Missouri, Washington, North Carolina, Michigan, Maryland, South Carolina, Arizona, and Georgia. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services.
American Oncology Network (American Oncology Network) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AONCW has been successfully added to your